These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 7958464)

  • 1. Regulatory issues relating to the use of recombinant vectors in production of human vaccines.
    Marcus-Sekura CJ
    Dev Biol Stand; 1994; 82():107-12. PubMed ID: 7958464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Confirming the safety characteristics of recombinant vectors used in veterinary medicine: a regulatory perspective.
    Gay CG; Roth HJ
    Dev Biol Stand; 1994; 82():93-105. PubMed ID: 7958487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A view on regulatory aspects of live viral vaccine safety.
    Horaud F
    Dev Biol Stand; 1994; 82():113-8. PubMed ID: 7958465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lessons from preventive infectious disease vaccines.
    Chandler DK; Midthun K; Goldenthal KL
    Dev Biol (Basel); 2004; 116():61-6; discussion 69-76. PubMed ID: 15603184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation and review of DNA vaccine products.
    Smith HA
    Dev Biol (Basel); 2000; 104():57-62. PubMed ID: 11713825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lessons learned from independent central review.
    Ford R; Schwartz L; Dancey J; Dodd LE; Eisenhauer EA; Gwyther S; Rubinstein L; Sargent D; Shankar L; Therasse P; Verweij J
    Eur J Cancer; 2009 Jan; 45(2):268-74. PubMed ID: 19101138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulations for vaccines against emerging infections and agrobioterrorism in the United States of America.
    Elsken LA; Carr MY; Frana TS; Brake DA; Garland T; Smith K; Foley PL
    Rev Sci Tech; 2007 Aug; 26(2):429-41. PubMed ID: 17892163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetically engineered vaccines: an overview.
    Dertzbaugh MT
    Plasmid; 1998; 39(2):100-13. PubMed ID: 9514708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulations and procedures in parasite vaccine development.
    Schetters TP; Gravendyck M
    Parasitology; 2006; 133 Suppl():S189-95. PubMed ID: 17274846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fowlpox virus as a recombinant vaccine vector for use in mammals and poultry.
    Skinner MA; Laidlaw SM; Eldaghayes I; Kaiser P; Cottingham MG
    Expert Rev Vaccines; 2005 Feb; 4(1):63-76. PubMed ID: 15757474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poxviruses as vaccine vectors.
    Pastoret PP; Vanderplasschen A
    Comp Immunol Microbiol Infect Dis; 2003 Oct; 26(5-6):343-55. PubMed ID: 12818621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory expectations during product development for tumour vaccines.
    Kawakami K; Puri RK
    Dev Biol (Basel); 2004; 116():53-9; discussion 69-76. PubMed ID: 15603183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Canadian regulatory requirements for recombinant fish vaccines.
    Sethi MS; Gifford GA; Samagh BS
    Dev Biol Stand; 1997; 90():347-53. PubMed ID: 9270863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fish vaccine antigens produced or delivered by recombinant DNA technologies.
    Leong JC; Anderson E; Bootland LM; Chiou PW; Johnson M; Kim C; Mourich D; Trobridge G
    Dev Biol Stand; 1997; 90():267-77. PubMed ID: 9270855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delegations of authority and organization; Center for Biologics Evaluation and Research, Center for Devices and Radiological Health, and Center for Drug Evaluation and Research--FDA. Final rule.
    Fed Regist; 1991 Nov; 56(225):58758-9. PubMed ID: 10115699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malaria vaccine.
    Khurana SK; Talib VH
    Indian J Pathol Microbiol; 1996 Dec; 39(5):433-41. PubMed ID: 9002371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assuring the quality, safety, and efficacy of DNA vaccines.
    Robertson JS; Griffiths E
    Mol Biotechnol; 2001 Feb; 17(2):143-9. PubMed ID: 11395863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-target effects of live vaccines: myth, reality and demagoguery.
    Levine MM
    Dev Biol Stand; 1995; 84():33-8. PubMed ID: 7796965
    [No Abstract]   [Full Text] [Related]  

  • 20. A review of vaccine research and development: the human immunodeficiency virus (HIV).
    Girard MP; Osmanov SK; Kieny MP
    Vaccine; 2006 May; 24(19):4062-81. PubMed ID: 16530298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.